Applied Therapeutics
APLT
APLT was delisted on the 2nd of February, 2026.
55 hedge funds and large institutions have $107M invested in Applied Therapeutics in 2023 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 14 increasing their positions, 7 reducing their positions, and 7 closing their positions.
221,267% more call options, than puts
Call options by funds: $19.9M | Put options by funds: $9K
214% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 7
166% more capital invested
Capital invested by funds: $40.3M → $107M (+$66.7M)
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
100% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 7
38% more funds holding
Funds holding: 40 → 55 (+15)
13.69% more ownership
Funds ownership: 54.39% → 68.08% (+14%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$5.6M |
| 2 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$2.88M |
| 3 |
KCM
Knoll Capital Management
Miami,
Florida
|
+$2.82M |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$1.97M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$1.47M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CM
CM Management
Gulf Breeze,
Florida
|
-$384K |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
-$347K |
| 3 |
Two Sigma Advisers
New York
|
-$150K |
| 4 |
Millennium Management
New York
|
-$61.1K |
| 5 |
JP Morgan Chase
New York
|
-$44K |
APLT Hedge Fund Activity: Q3 2023 in Review
55 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Applied Therapeutics (APLT) for Q3 2023, worth a combined $107M — up 166% from $40.3M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new APLT positions and 7 closed out — a net gain of 15 holders — while 14 added to existing stakes and 7 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $5.6M. The largest seller was CM Management, exiting entirely with an estimated $384K sold.
- 55 institutional investors held Applied Therapeutics (APLT) as of Q3 2023, up from 40 in Q2 2023.
- Funds reported $107M of Applied Therapeutics stock for Q3 2023, up 166% quarter-over-quarter.
- 22 funds opened new Applied Therapeutics positions in Q3 2023 and 7 closed out, a net change of +15 holders.
- The largest Applied Therapeutics buyer in Q3 2023 was Armistice Capital, an estimated $5.6M added.
- The largest Applied Therapeutics seller in Q3 2023 was CM Management, an estimated $384K sold.
Based on aggregated 13F filings for Q3 2023.